report

LOS ANGELES, CALIFORNIA - APRIL 17: In this photo illustration, boxes of the diabetes drug Ozempic rest on a drugstore counter on April 17, 2023 in Los Angeles, California.  Ozempic was originally approved by the FDA to treat people with type 2 diabetes, who risk serious health consequences without medication.  In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight-loss benefits, which has led to shortages.  Some doctors prescribe Ozempic off-label to treat obesity.  (Photo illustration by Mario Tama/Getty Images)

Ozempic users report stomach paralysis from diet drug: ‘So much hell’

Photo illustration by Mario Tama/Getty Images Since Ozempic was first released to the public in 2018, the diabetic injectable has become a favorite for fans, even those without diabetes, for weight loss. Others in its class of drugs, such as Wegovy, have also seen an increase in demand, so high that the Food and Drug …

Ozempic users report stomach paralysis from diet drug: ‘So much hell’ Read More »

New report exposes breadth of medical practices owned by private equity - UC Berkeley Public Health

New report exposes breadth of medical practices owned by private equity – UC Berkeley Public Health

The practice leads to higher consumer prices The American Antitrust Institute (AAI), in collaboration with the Petris Center on Health Care Markets and Consumer Welfare of the University of California at Berkeley (UCB) and the Washington Center for Equitable Growth (Equitable Growth), announced the publication of a new report on private equity ownership in healthcare. …

New report exposes breadth of medical practices owned by private equity – UC Berkeley Public Health Read More »

Scroll to Top